RICE HALL JAMES & ASSOCIATES, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,844,757
-43.9%
683,937
+23.8%
0.50%
-37.3%
Q2 2023$13,983,655
-46.3%
552,495
-31.7%
0.79%
-46.4%
Q1 2023$26,063,559
+61.3%
809,176
-7.6%
1.48%
+59.8%
Q4 2022$16,161,656
-33.2%
875,496
-2.4%
0.93%
-34.0%
Q3 2022$24,212,000
+61.4%
896,754
-17.4%
1.40%
+93.7%
Q2 2022$14,999,000
-30.8%
1,085,340
-2.4%
0.72%
-16.1%
Q1 2022$21,690,000
+19.3%
1,112,325
-0.1%
0.86%
+34.0%
Q4 2021$18,180,000
-29.1%
1,113,945
+21.1%
0.64%
-31.9%
Q3 2021$25,625,000
-6.6%
919,760
-0.7%
0.95%
-3.0%
Q2 2021$27,443,000
-11.3%
925,890
-16.3%
0.98%
-3.2%
Q1 2021$30,928,000
-2.7%
1,106,547
-1.3%
1.01%
-9.8%
Q4 2020$31,773,000
+11.8%
1,121,152
-0.8%
1.12%
-2.4%
Q3 2020$28,409,000
+12.6%
1,130,016
+9.4%
1.14%
+5.7%
Q2 2020$25,233,000
+65.5%
1,033,279
+0.3%
1.08%
+27.1%
Q1 2020$15,248,000
-11.9%
1,030,281
-3.4%
0.85%
+45.6%
Q4 2019$17,303,000
+23.4%
1,066,128
-1.2%
0.58%
+16.8%
Q3 2019$14,023,000
+22.5%
1,078,697
+22.2%
0.50%
+31.8%
Q2 2019$11,450,000
+520.6%
882,769
+654.1%
0.38%
+544.1%
Q1 2019$1,845,000
+176.2%
117,068
+252.7%
0.06%
+145.8%
Q4 2018$668,000
+10.2%
33,193
+36.2%
0.02%
+9.1%
Q3 2018$606,00024,3720.02%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders